Work
Programs, a laboratory and two companies.
Each began with a problem met in clinic: a patient who could not get seen in time, a referral that went nowhere, a note that took longer than the visit.
Clinical leadership
Chief of Cardiology, Mount Sinai West, since 2020. Associate Director, Cardiovascular Institute, since 2023.
Since 2017 Dr. Bander has helped turn cardiology at Mount Sinai West into a full-spectrum program. Between 2017 and 2025, outpatient volume grew by about 125 percent and cardiac testing by about 150 percent.
- Rapid Cardiac Evaluation UnitAn urgent outpatient cardiac clinic, a walk-in alternative to the emergency room with on-site testing for chest pain and related symptoms. It was the first of its kind at Mount Sinai. Program page · 2019 abstract
- Coronary CT angiographyA new program that brought advanced coronary imaging in-house and shortened diagnostic turnaround.
- Amyloid programA new program for cardiac amyloidosis, reducing the need to send patients elsewhere.
- EchocardiographyA redesigned and expanded laboratory, and an offsite program performing more than 1,000 echocardiograms a year in primary care offices across ten New York City sites.
- Skilled nursing facilitiesA heart failure program for patients discharged to skilled nursing facilities, reported in the Journal of Cardiac Failure and JACC.
- Incidental coronary calciumA program that reviews chest CT scans done for other reasons, finds coronary calcium that was never acted on, and brings those patients to cardiology for prevention.
- New in 2025A coronary plaque analysis and CT-derived fractional flow reserve program, an obstetric cardiology program, and a cardiac screening program with five union partners.
- System imagingLeads work to centralize CT, PET and echocardiography operations across the health system.
Figures are from Dr. Bander’s curriculum vitae, November 2026.
MSW AI Lab
Founder and Director of the Agentic Laboratory at Mount Sinai West, part of the Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai.
A research laboratory built on one idea: the people who know the clinical workflow should be the ones who build the software. Physicians, nurses and program staff develop tools with current AI methods, study them, and share what they learn with academia and industry. The aims are lower cost and better patient care.
- DocumentationAn AI scribe built in the clinic, presented at the American Heart Association Scientific Sessions in 2025 and at TCT in 2026.
- Heart failureDecision support for skilled nursing facilities, published in JACC: Case Reports in 2026, and research on voice analysis in heart failure.
- Patient outreachConversational AI for pre-procedure calls before cardiac catheterization, with colleagues in the catheterization laboratory; published in npj Digital Medicine in 2026.
- Population programsThe application behind the first-responder hypertension program, and tools for lipid management.
- Operations and researchTools for inpatient rounds, clinic scheduling and capacity, and extracting data from research protocols.
- Safety reviewDr. Bander chairs the lab’s AI Safety Review Board, which evaluates each clinical AI application before it is deployed.
- AdvisorsA medical advisory board of Annapoorna Kini, MD (chair), Deepak Bhatt, MD, and Roxana Mehran, MD, with technical advisors including Jack Hidary, chief executive of SandboxAQ.
- TeachingOpen courses on secure coding and an introduction to AI, and the AI curriculum he directs for the Women As One CLIMB program.
Quantum sensing for the heart
Principal investigator, SandboxAQ magnetocardiography studies, since 2023.
Magnetocardiography records the magnetic field produced by the heart’s electrical activity. Dr. Bander has led studies at Mount Sinai testing whether an unshielded bedside device, paired with AI analysis, can help detect ischemia in patients who come to the emergency department with chest pain.
- Oct 2025 – present
PRISM2
Open-label, multi-arm prospective investigation of ischemia using the SandboxAQ magnetocardiography device.
- Aug 2024 – Aug 2025
DUET
Magnetocardiography in patients with elevated troponin.
- Oct 2023 – Jul 2025
MCG Discovery
Magnetocardiography in emergency departments.
Presented at the American Heart Association Scientific Sessions (Circulation, 2024), the SandboxAQ annual conference (2025) and the American College of Cardiology Scientific Session (JACC, 2026). Registered on ClinicalTrials.gov: MCG Discovery, DUET, PRISM. These are research studies; the device is investigational.
First responders
Co-founder and leader, Hypertension Prevention Program for first responders at Mount Sinai, since 2017.
With the Uniformed Fire Officers Association, Dr. Bander co-founded a program that finds fire officers with high blood pressure and connects them to treatment. Members receive a Bluetooth blood pressure cuff at no cost, and Mount Sinai clinicians follow their readings remotely.
- Who it servesAbout 2,000 enrolled members of FDNY and NYPD unions: the Uniformed Fire Officers Association, the Uniformed Firefighters Association and the Uniformed Fire Alarm Dispatchers Benevolent Association; and the Lieutenants Benevolent Association, the Captains Endowment Association and the Detectives’ Endowment Association.
- How it worksTelehealth screening, home monitoring and clinician follow-up, first reported in JACC in 2020 and presented at national meetings in 2025.
- SupportProgram Director for the Atria Health Collaborative award that supported the program in 2024–2025. Atria’s description
- Cardiac screeningA screening program with five union partners to detect heart disease before symptoms appear.
- World Trade CenterCo-author of the first report of cardiac dysfunction following exposure to the World Trade Center disaster (JACC, 2010).
- RecognitionAward of Excellence, Uniformed Fire Officers Association (2018). Leaders of the Finest Award, Lieutenants Benevolent Association of the NYPD (2026).
Ventures
Two companies, each founded to close a gap he met in practice.
ReferWell
A nationwide referral connectivity system that began as Urgent Consult. ReferWell provides referral management, scheduling and care navigation to health plans, accountable care organizations and health systems, so that a referral leads to a completed visit.
referwell.comProvider Loop
Designed and implemented a heart failure readmission-reduction program for nursing homes, using remote monitoring to keep patients well after discharge and their care teams in step.
COVID-19 response
New York, 2020 – 2021.
In the first months of the pandemic, Dr. Bander helped connect recovered patients in New York’s Orthodox Jewish community with Mount Sinai’s convalescent plasma program, and later helped bring antibody treatments to outpatients.
- Convalescent plasmaHelped direct community donors to the hospital’s plasma program, as reported by The Forward, and co-authored the Mount Sinai study of plasma treatment in Nature Medicine (2020).
- Hyperimmune globulinRecruited antibody donors for a Mount Sinai trial of a new hyperimmune globulin. Mount Sinai Today
- Monoclonal antibodiesPresented Mount Sinai’s outpatient treatment experience to hospitals across New York State and to the National Hispanic Medical Association. HANYS webinar
- ResearchSenior author of a JACC review on SARS-CoV-2 and the renin–angiotensin system, and sub-investigator on the FREEDOM COVID anticoagulation trial.
Comprehensive, concierge and international care
As chief, Dr. Bander expanded the Comprehensive Health Program at Mount Sinai West, which offers personalized, evidence-based evaluation aimed at finding problems early, and broadened concierge and international services for patients who travel to New York for cardiac care.
He also leads AI and quantum-sensing initiatives with international partners, and spoke on clinical innovation and entrepreneurship at the ARC Summit in Tel Aviv in 2026.